Patient access schemes agreed through NICE should be made more transparent. This is according to Paul McManus, a pharmacist and …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

